epirubicin has been researched along with Sensation Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, KG; Eckhoff, L; Gärtner, R; Jensen, MB; Kehlet, H; Kroman, N | 1 |
1 other study(ies) available for epirubicin and Sensation Disorders
| Article | Year |
|---|---|
Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Sectional Studies; Cyclophosphamide; Denmark; Docetaxel; Epirubicin; Female; Fluorouracil; Foot; Hand; Humans; Lymph Node Excision; Mastectomy; Middle Aged; Multivariate Analysis; Neuralgia; Pain Measurement; Prevalence; Prospective Studies; Radiotherapy; Risk Factors; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Taxoids | 2012 |